Works by Li, Mengtao


Results: 244
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial.

    Published in:
    BioDrugs, 2020, v. 34, n. 3, p. 381, doi. 10.1007/s40259-020-00408-z
    By:
    • Su, Jinmei;
    • Li, Mengtao;
    • He, Lan;
    • Zhao, Dongbao;
    • Wan, Weiguo;
    • Liu, Yi;
    • Xu, Jianhua;
    • Xu, Jian;
    • Liu, Huaxiang;
    • Jiang, Lindi;
    • Wu, Huaxiang;
    • Zuo, Xiaoxia;
    • Huang, Cibo;
    • Liu, Xiumei;
    • Li, Fen;
    • Zhang, Zhiyi;
    • Liu, Xiangyuan;
    • Dong, Lingli;
    • Li, Tianwang;
    • Chen, Haiying
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50